Insiders HeraMED Limited

Equities

Market Closed - Australian S.E. Other stock markets 12:24:19 2024-05-15 am EDT			5-day change	1st Jan Change
0.015 ^AUD	0.00%		-16.67%	-37.50%

May. 13	Transcript : HeraMED Limited - Special Call
May. 08	HeraMED Obtains ASIC Approval for Extension to Hold 2024 Meeting	MT

Heramed Limited Announces Board Changes	Mar. 11	CI
HeraMED Limited Announces Emily Slade to Resign as Non-Executive Director	Jan. 16	CI
HeraMED CEO Steps Down; CFO Transitions to EVP Role; Shares Surge 33%	Nov. 07	MT
HeraMED Limited Limited Announces Resignation of David Groberman as Chief Executive Officer with Immediate Effect	Nov. 07	CI
HeraMED Limited Announces Resignation of David Groberman as Managing Director	Nov. 07	CI
HeraMED Transitions Chair to Executive Role	23-07-03	MT
Heramed Limited Announces Board Changes	23-04-19	CI
Heramed Appoints President for North American Unit	23-01-23	MT
HeraMED Limited Announces Appointment of Keith Koby as President, North America	23-01-23	CI
HeraMED Limited Appoints Emily Slade as Non-Executive Director	22-09-12	CI
HMD Appoints Anoushka Gungadin as Director of Strategic Partnerships Australia and New Zealand	22-07-25	CI
HeraMED Limited Announces Change of Company Secretary; Announces Changes Registered Address	20-03-01	CI
HeraMED Appoints Alexander Radke as General Manager of US Operations	20-02-02	CI
HeraMED Limited Appoints Paul A. Friedman to Company's Advisory Board	19-05-19	CI
HeraMED Limited Appoints Arturo Weschler MD, as VP of Innovation	19-03-25	CI
HeraMED Limited Appoints Doron Birger as Director	18-12-10	CI
HeraMED Limited Appoints Ronald Weinberger as Director	18-12-10	CI
HeraMED Limited Appoints Tal Slonim as Director	18-12-10	CI
HeraMED Limited Appoints David Groberman as Director	18-12-10	CI
HeraMED Limited Appoints David Hinton as Director	18-12-10	CI

No results for this search